BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

8 Bromo Cyclic Adenosine Monophosphate

A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.

101+ PubMed studies analyzed · Evidence Score: 42

Research Domains

8 Bromo Cyclic Adenosine Monophosphate has been studied across 25 research domains including 🧬 Hormones, 🔬 Oncology, 🦴 Bone & Joint, 🔬 Inflammation, 🫘 Kidney. The primary research focus is 🧬 Hormones with 25% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with 8 Bromo Cyclic Adenosine Monophosphate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

roflumilast
2 shared targets
cilomilast
2 shared targets
piclamilast
2 shared targets
rolipram
2 shared targets
cdp840
2 shared targets
rolipram
2 shared targets
crisaborole
2 shared targets
ibudilast
2 shared targets
Enoximone
2 shared targets
streptonigrin
2 shared targets
Loading evidence profile...

This evidence profile for 8 Bromo Cyclic Adenosine Monophosphate is generated deterministically from 101 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.